Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman LLP Represents Joseph Gunnar & Co. in $3.25 Million Registered Direct Offering

Northwest Biotherapeutics ("NWBO"), a biotechnology company focused on developing personalized immune therapies for cancer, registered direct offering of common stock shares, facilitated by Joseph Gunnar & Co. This transaction, conducted under a shelf S-3 registration, culminated on June 5th. The shares were strategically placed with SIO Capital Management, generating substantial gross proceeds amounting to $3.25 million.

Lucosky Brookman served as counsel to Joseph Gunnar & Co., LLC, who acted as a placement agent in this registered direct offering.